BMJ Paediatrics Open (Oct 2021)

SARS CoV-2 seroprevalence in a US school district during COVID-19

  • Benjamin Lee,
  • Beth D Kirkpatrick,
  • Sally Cook,
  • Sean S M Bullis,
  • Benjamin Grebber,
  • Nancy R Graham,
  • Marya Carmolli,
  • Dorothy Dickson,
  • Sean A Diehl

DOI
https://doi.org/10.1136/bmjpo-2021-001259
Journal volume & issue
Vol. 5, no. 1

Abstract

Read online

Reduced symptomatology and access to testing in children have led to underestimates of paediatric COVID-19 prevalence and raised concerns about school safety. To explore COVID-19 prevalence and risk factors in school settings, we conducted a SARS-CoV-2 serosurvey in a Vermont, USA school district in December 2020. Among 336 students (63%) and 196 teachers/staff (37%), adjusted seroprevalence was 4.7% (95% CI 2.9 to 7.2) and was lowest in preK-5 students (4–10 Years). Seroprevalence was 10-fold higher than corresponding state PCR data but was low overall with no evidence of onward transmissions. These results further support feasibility of in-person learning during COVID-19 with appropriate mitigation measures.